MORPHEUS: A phase Ib/II multi-trial platform evaluating the safety and efficacy of cancer immunotherapy (CIT)-based combinations in patients (pts) with non-small cell lung cancer (NSCLC).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS9105-TPS9105 ◽  
Author(s):  
Melissa Lynne Johnson ◽  
Benjamin J. Solomon ◽  
Mark M. Awad ◽  
Byoung Chul Cho ◽  
Justin F. Gainor ◽  
...  
2020 ◽  
Vol 111 (6) ◽  
pp. 1933-1942
Author(s):  
Shintaro Kanda ◽  
Yuichiro Ohe ◽  
Yasushi Goto ◽  
Hidehito Horinouchi ◽  
Yutaka Fujiwara ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e20522-e20522 ◽  
Author(s):  
Alex A. Adjei ◽  
Jaafar Bennouna ◽  
Natasha B. Leighl ◽  
Enriqueta Felip ◽  
Diego Luigi Cortinovis ◽  
...  

2020 ◽  
Vol Volume 12 ◽  
pp. 5975-5985
Author(s):  
Peng Song ◽  
Dongliang Yang ◽  
Xiaoxia Cui ◽  
Hanping Wang ◽  
Xiaoyan Si ◽  
...  

The Lancet ◽  
2019 ◽  
Vol 394 (10212) ◽  
pp. 1904-1905
Author(s):  
Tony S K Mok ◽  
Jin Zhang ◽  
Gilberto Lopes

Sign in / Sign up

Export Citation Format

Share Document